These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4404279)

  • 1. The use of prindolol (Visken) in the treatment of hypertension.
    Morgan TO; Louis WJ; Dawborn JK; Doyle AE
    Med J Aust; 1972 Aug; 2(6):309-12. PubMed ID: 4404279
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experiences with prindolol (Visken) in the therapy of hypertension.
    Seedat YK; Stewart-Wynne E
    S Afr Med J; 1972 Oct; 46(41):1524-6. PubMed ID: 4405054
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiences with beta-adrenergic blockade drugs in hypertension.
    Seedat YK; Stewart-Wynne EG; Reddy J; Randeree M
    S Afr Med J; 1973 Feb; 47(7):259-62. PubMed ID: 4143987
    [No Abstract]   [Full Text] [Related]  

  • 4. Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.
    Collins IS; King IW
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):185-94. PubMed ID: 4402011
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment with the preparation "Visken" (beta blocking agent) in angina pectoris].
    Mihail A; Popescu P; Petrescu X; Popa N
    Med Interna (Bucur); 1972 Aug; 24(8):925-32. PubMed ID: 4404181
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled study of prindolol (Visken) in hypertension.
    Thorpe P
    Med J Aust; 1972 Aug; 2(6):306-9. PubMed ID: 4563156
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of tachycardial disturbances of the cardiac rhythm with a beta-adrenergic blocking agent (Visken)].
    Ley H; Ohlen J; von Richthofen W
    Munch Med Wochenschr; 1970 Nov; 112(48):2183-6. PubMed ID: 4098955
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of adrenergic-blocking drugs.
    Louis WJ; Rand MJ; McNeil JJ; Drummer O; Jarrott B
    Cardiology; 1979; 64 Suppl 1():96-104. PubMed ID: 42490
    [No Abstract]   [Full Text] [Related]  

  • 10. Methyldopa (Aldomet) in combination with timolol (Blocadren) in the treatment of hypertension.
    Seedat YK
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):10-8. PubMed ID: 8279
    [No Abstract]   [Full Text] [Related]  

  • 11. Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.
    Stokes GS; Frost GW; Graham RM; MacCarthy EP
    Clin Pharmacol Ther; 1979 Jun; 25(6):783-9. PubMed ID: 36250
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of beta-blockader visken in children with primary arterial hypertension].
    Nadezhdina EA; Vul'fson IN; Ivanitskaia IN; Kurbatov VS; Kupriianova OO
    Kardiologiia; 1976 May; 16(5):71-5. PubMed ID: 7701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance].
    Rodrigues R; Kornfeld J; Pereira EM
    Arq Bras Cardiol; 1972 Dec; 25(6):471-5. PubMed ID: 4145022
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of lb 46, a new beta-adrenergic antagonist, in hyperthyroidism. Heart rate and blood pressure at rest and during exercise.
    Runeberg L; Kreus KE
    Acta Med Scand; 1971 May; 189(5):423-6. PubMed ID: 4397076
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-adrenergic blocking drugs in the management of hypertension.
    Bergman SM; Wallin JD
    Compr Ther; 1987 Nov; 13(11):58-62. PubMed ID: 2890462
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
    Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.